Colonial River Wealth Management LLC Has $1.67 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Colonial River Wealth Management LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 30.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,166 shares of the healthcare conglomerate’s stock after acquiring an additional 733 shares during the quarter. UnitedHealth Group accounts for approximately 1.0% of Colonial River Wealth Management LLC’s investment portfolio, making the stock its 24th biggest holding. Colonial River Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,667,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in UNH. Kraft Davis & Associates LLC lifted its position in shares of UnitedHealth Group by 3.4% during the 3rd quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock worth $294,000 after buying an additional 19 shares in the last quarter. Iron Horse Wealth Management LLC increased its stake in shares of UnitedHealth Group by 1.6% during the 3rd quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock worth $614,000 after purchasing an additional 19 shares during the last quarter. Secure Asset Management LLC increased its stake in shares of UnitedHealth Group by 0.8% during the 3rd quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock worth $1,238,000 after purchasing an additional 19 shares during the last quarter. Bensler LLC increased its stake in shares of UnitedHealth Group by 0.3% during the 3rd quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock worth $3,677,000 after purchasing an additional 19 shares during the last quarter. Finally, Texas Capital Bancshares Inc TX grew its stake in UnitedHealth Group by 1.1% in the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock valued at $855,000 after buying an additional 19 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $458.16 on Wednesday. The company has a market cap of $422.39 billion, a price-to-earnings ratio of 19.22, a price-to-earnings-growth ratio of 1.33 and a beta of 0.54. The company has a 50-day moving average price of $500.89 and a 200-day moving average price of $518.93. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62. UnitedHealth Group Incorporated has a 12 month low of $445.68 and a 12 month high of $554.70.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, beating the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The firm had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. During the same period in the prior year, the firm posted $5.34 earnings per share. The company’s quarterly revenue was up 14.1% compared to the same quarter last year. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.82 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a dividend yield of 1.64%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 31.54%.

Analysts Set New Price Targets

A number of research firms recently weighed in on UNH. HSBC reiterated a “reduce” rating and issued a $480.00 price objective (down from $550.00) on shares of UnitedHealth Group in a research note on Monday, December 18th. Oppenheimer reiterated an “outperform” rating and issued a $610.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Bank of America restated a “buy” rating and set a $675.00 price target on shares of UnitedHealth Group in a research report on Thursday, March 7th. Royal Bank of Canada restated an “outperform” rating and set a $596.00 price target on shares of UnitedHealth Group in a research report on Thursday, February 29th. Finally, Piper Sandler reduced their price target on shares of UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a research report on Wednesday, January 17th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $579.33.

Check Out Our Latest Research Report on UNH

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.